HemoBioTech receives unmistakeable someone is concerned HemoTech treatment of clever blood detriment
HemoBioTech (Pink Sheets:HMBT) announced today the issuance of a late-model tangible US 7,759,306 B2, "Methods of Aztec hop Grave Blood Loss." HemoBioTech has an private worldwide approve from Texas Tech University to commercialize the technology. The recent unequivocal continues to May 16, 2026.
“The main improvement in HemoTech is the quick-wittedness of Adenosine which has anti-inflammatory activity.”
The late-model flagrant involves HemoTech which induces the fabrication of uncharted red blood cells in the main part. Uses an eye to HemoTech could connect with the treatment of excruciating blood downfall and anemia in trauma, surgery, cancer, kidney murrain and magnanimity murrain. The exchange on the side of treatment of severe anemia is ended $2 billion.
HemoTech also has the usefulness of delivering oxygen to conglomeration in the stiff since it is composed of modified hemoglobin. The cartel of delivering oxygen and inducing uncharted red blood cells could be an help to tourista trauma, elective surgery in third the world at large countries plagued with a huge amount of HIV or Hepatitis contaminated blood and fitted take advantage of above all the military and homeland safety.
HemoTech is composed of bovine hemoglobin, which is chemically modified with ATP, Adenosine and GSH, to triumph over toxicity. HemoTech has been euphemistic pre-owned successfully in an introductory clinical ruminate on to premium children afflicted with sickle cubicle anemia, with no seeming side affects. HemoTech stabilizes a room representative called Hif-1 alpha, which results in induction of erythropoietin, which stimulates an proliferating in moulding of additional red blood cells.
"HemoTech addresses a multi-billion dollar merchandise fitted treatment of discerning blood downfall and anemia with the hidden superiority of fewer side affects and the cleverness to convey oxygen in sharp-witted situations," said Dr. Arthur P. Bollon, Chief Gubernatorial Catchpole of HemoBioTech. "The dominant rise in HemoTech is the company of Adenosine which has anti-inflammatory activity."
START : HemoBioTech
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
